BR100 Increased By (0.52%)
BR30 Increased By (0.44%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.58%)
BECO 5.67 Decreased By ▼ -0.06 (-1.05%)
BML 57.05 Decreased By ▼ -0.25 (-0.44%)
BOP 36.85 Increased By ▲ 0.08 (0.22%)
CNERGY 8.32 Decreased By ▼ -0.07 (-0.83%)
DCL 11.90 Decreased By ▼ -0.14 (-1.16%)
FCCL 58.66 Increased By ▲ 0.05 (0.09%)
FCSC 5.09 Increased By ▲ 0.08 (1.6%)
FFL 18.12 Increased By ▲ 0.18 (1%)
FNEL 1.26 No Change ▼ 0.00 (0%)
HUMNL 11.28 Decreased By ▼ -0.14 (-1.23%)
KEL 8.24 Decreased By ▼ -0.05 (-0.6%)
KOSM 6.54 Decreased By ▼ -0.08 (-1.21%)
MLCF 107.17 Decreased By ▼ -1.12 (-1.03%)
NBP 208.80 Increased By ▲ 2.76 (1.34%)
PACE 11.18 Increased By ▲ 0.01 (0.09%)
PAEL 45.39 Increased By ▲ 0.04 (0.09%)
PIAHCLA 30.31 Decreased By ▼ -0.46 (-1.49%)
PIBTL 18.87 Decreased By ▼ -0.19 (-1%)
PPL 248.71 Increased By ▲ 2.76 (1.12%)
PRL 36.29 Increased By ▲ 0.21 (0.58%)
PTC 74.01 Increased By ▲ 1.65 (2.28%)
SEARL 96.13 Decreased By ▼ -0.54 (-0.56%)
SSGC 31.37 Decreased By ▼ -0.30 (-0.95%)
TELE 9.21 Decreased By ▼ -0.06 (-0.65%)
THCCL 68.04 Increased By ▲ 0.23 (0.34%)
TPLP 11.64 Increased By ▲ 0.41 (3.65%)
TREET 25.72 Decreased By ▼ -0.17 (-0.66%)
TRG 67.62 Decreased By ▼ -0.22 (-0.32%)
WAVES 11.25 Increased By ▲ 0.27 (2.46%)
WTL 1.28 No Change ▼ 0.00 (0%)
By

SYDNEY: Australian shares rose to three-week closing highs on Tuesday, helped by gains in heavyweight financials and iron ore miners, while signs of steadying employment and improving business conditions added to investor confidence.

The S&P/ASX 200 index settled 0.5% higher at 6,138.7, its highest close since July 21, in low-volume trading. Leading the charge, financials rose more than 1%, with the 'big four' banks climbing in a range of 1% to 2.7%.

Among gainers, shares of some iron ore miners rose as futures on China's Dalian Commodity Exchange jumped on falling portside inventories and upbeat demand, with BHP Group and Rio Tinto gaining 0.9% each. Gold stocks fell over 4% as bullion prices retreated on a stronger dollar.

Newcrest Mining, the country's largest independent gold miner, lost 2.8%, while Northern Star Resources dropped 5%. Biotech firm Mesoblast dropped more than 30% after a US FDA committee questioned the efficacy of one of its leading drug candidates. New Zealand's benchmark S&P/NZX 50 index slipped 0.3% to 11,645.3, dragged by losses in healthcare and consumer stocks.

Comments

Comments are closed for this article.